ARIAD PHARMACEUTICALS INC's ticker is ARIA and the CUSIP is 04033A100. A total of 165 filers reported holding ARIAD PHARMACEUTICALS INC in Q1 2016. The put-call ratio across all filers is 0.75 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $2,567,000 | -2.7% | 206,352 | +7.1% | 0.01% | 0.0% |
| Q3 2016 | $2,639,000 | +89.4% | 192,738 | +2.2% | 0.01% | +75.0% |
| Q2 2016 | $1,393,000 | +25.4% | 188,563 | +8.4% | 0.00% | +33.3% |
| Q1 2016 | $1,111,000 | +2.0% | 173,888 | -0.2% | 0.00% | -25.0% |
| Q4 2015 | $1,089,000 | +15.4% | 174,193 | +7.8% | 0.00% | +33.3% |
| Q3 2015 | $944,000 | -28.0% | 161,633 | +1.9% | 0.00% | -25.0% |
| Q2 2015 | $1,312,000 | -2.5% | 158,638 | -2.8% | 0.00% | 0.0% |
| Q1 2015 | $1,345,000 | +42.8% | 163,263 | +19.0% | 0.00% | +33.3% |
| Q4 2014 | $942,000 | +22.5% | 137,188 | -3.7% | 0.00% | +50.0% |
| Q3 2014 | $769,000 | -14.9% | 142,406 | +0.3% | 0.00% | -33.3% |
| Q2 2014 | $904,000 | -21.9% | 141,986 | -1.1% | 0.00% | 0.0% |
| Q1 2014 | $1,157,000 | +12.5% | 143,512 | -4.8% | 0.00% | 0.0% |
| Q4 2013 | $1,028,000 | -66.7% | 150,749 | -10.1% | 0.00% | -70.0% |
| Q3 2013 | $3,084,000 | +2.9% | 167,622 | -2.2% | 0.01% | 0.0% |
| Q2 2013 | $2,997,000 | – | 171,370 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 12,850,000 | $80,313,000 | 15.61% |
| Opaleye Management Inc. | 1,310,000 | $8,188,000 | 3.42% |
| Camber Capital Management LP | 5,405,235 | $33,783,000 | 2.18% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 471,516 | $2,947,000 | 1.22% |
| HighVista Strategies LLC | 807,100 | $5,044,000 | 0.94% |
| JS Capital Management LLC | 630,000 | $3,938,000 | 0.94% |
| 1492 Capital Management LLC | 202,500 | $1,266,000 | 0.92% |
| Palo Alto Investors LP | 2,257,217 | $14,108,000 | 0.78% |
| Geduld E E | 185,100 | $1,157,000 | 0.72% |
| Elk Creek Partners, LLC | 1,592,527 | $9,953,000 | 0.71% |